Skip to content
10-K

Annual Report

Advanced BioMedical Technologies, Inc.

0001493152-21-002055

← back to feed
Filed
Jan 29, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Jan 29, 2021 70.22M sh
Shares Diluted FY 2020 · Oct 31, 2020 70.1M sh
Shares Diluted FY 2020 · Oct 31, 2019 69.63M sh
Capex FY 2020 · Oct 31, 2020 $30.71K
Capex FY 2020 · Oct 31, 2019 $18.57K
Operating Cash Flow FY 2020 · Oct 31, 2020 $646.66K
Operating Cash Flow FY 2020 · Oct 31, 2019 −$742.53K
Cash And Equivalents FY 2020 · Oct 31, 2020 $201.66K
Cash And Equivalents FY 2020 · Oct 31, 2019 $5.59K
Stockholders Equity FY 2020 · Oct 31, 2020 −$7.4M
Stockholders Equity FY 2020 · Oct 31, 2019 −$6.48M
Current Liabilities FY 2020 · Oct 31, 2020 $7.86M
Current Liabilities FY 2020 · Oct 31, 2019 $6.7M
Current Assets FY 2020 · Oct 31, 2020 $330.95K
Current Assets FY 2020 · Oct 31, 2019 $119.47K
Total Assets FY 2020 · Oct 31, 2020 $469.23K
Total Assets FY 2020 · Oct 31, 2019 $218.5K
Sga Expense FY 2020 · Oct 31, 2020 $224.46K
Sga Expense FY 2020 · Oct 31, 2019 $324.01K
Rd Expense FY 2020 · Oct 31, 2020 $182.96K
Rd Expense FY 2020 · Oct 31, 2019 $263.64K
Net Income FY 2020 · Oct 31, 2020 −$672K
Net Income FY 2020 · Oct 31, 2019 −$948.82K
Operating Income FY 2020 · Oct 31, 2020 −$446.62K
Operating Income FY 2020 · Oct 31, 2019 −$604.74K
Gross Profit FY 2020 · Oct 31, 2020 $71.77K
Gross Profit FY 2020 · Oct 31, 2019 $4.06K
Cost Of Revenue FY 2020 · Oct 31, 2020 $51.82K
Cost Of Revenue FY 2020 · Oct 31, 2019 $7.6K
Revenue FY 2020 · Oct 31, 2020 $123.59K
Revenue FY 2020 · Oct 31, 2019 $11.66K